Cerebrovascular disease in patients with type 2 diabetes mellitus

Close metadata

Recommended articles:

Integrative assessment of the effectiveness and safety of outpatient use of Picamilon. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):119-130

Place of oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH in the therapy and rehabilitation of patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):56-63

Posterior reversible encephalopathy syndrome in autoimmune disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):50-57

Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):71-80

Recognan (citicoline) prescribing in cerebrovascular diseases and type 2 diabetes mellitus patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):23-27

Skin alterations as possible clinical markers of diabetes mellitus and metabolic syndrome. Russian Journal of Preventive Medicine. 2024;(7):101-107

Effectiveness of recombinant interferon alpha in prevention of candida infection in patients at risk. Russian Journal of Clinical Dermatology and Venereology. 2024;(4):405-414

Prevalence of diabetic retinopathy assessed using two-field mydriatic fundus photography. Russian Annals of Ophthalmology. 2024;(4):60-67

The role of quantitative body composition analysis in population in the assessment and monitoring of cardiovascular risk metabolic factors. Russian Journal of Preventive Medicine. 2024;(12):128-134

Restoration of spermatogenesis suppressed by the use of testosterone, antiestrogen therapy in men with type 2 diabetes mellitus. Russian Journal of Human Reproduction. 2024;(6):156-160

The article discusses the current trends in the spread of carbohydrate disorders, discusses in more detail the problem of type 2 diabetes mellitus and associated cerebrovascular diseases. The spectrum of the therapeutic effect of the drugs neurox and neupilept is considered in relation to this category of patients.

Keywords:

diabetes mellitus

cerebrovascular diseases

neurox

neupilept

Authors:

Shishkova V.N.

National Medical Research Center for Therapy and Preventive Medicine Federal State Budgetary Institution the Ministry of Health of Russia;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry Federal State Budgetary Educational Institution of Higher Education

SPIN RSCI: 8507-5980
Scopus AuthorID: 25932318700
ResearcherID: AAJ-2413-2021
ORCID: 0000-0002-1042-4275

Adasheva T.V.

Evdokimov Moscow State University of Medicine and Dentistry

SPIN RSCI: 6923-0509
Scopus AuthorID: 57497595200
ResearcherID: J-5713-2013
ORCID: 0000-0002-3763-8994

Received:

13.05.2021

Accepted:

01.06.2021

List of references:

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition. Diabetes Res Clin Pract. 2019;157:107843. Epub 2019 Sep 10. https://doi.org/10.1016/j.diabres.2019.107843
Shestakova MV, Vikulova OK, Zheleznyakova AV, et al. Diabetes epidemiology in russia: what has changed over the decade? Terapevticheskii Arkhiv. 2019;91(10):4-13. (In Russ.). https://doi.org/10.26442/00403660.2019.10.000364
Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes Mellitus. 2016;19(2):104-112. (In Russ.). https://doi.org/10.14341/DM2004116-17
Shishkova VN. The mechanisms of developmentcardiovascular disease and type 2 diabetes: the role of insulin resistance, hyperinsulinemia and hypoadiponektinemia. Treatment and management. Systemic Hypertension. 2014;2:48-53. (In Russ.).
Shishkova VN. mechanisms of cardiovascular diseases development in obesity and insulin resistance: focus on atherothrombosis. Russian Journal of Cardiology. 2016;21(9):72-78. (In Russ.). https://doi.org/10.15829/1560-4071-2016-9-72-78
Dedov II, Shestakova MV, Vikulova OK et al. Atlas of diabetes register in russian federation, status 2018. Diabetes Mellitus. 2019;22(2-2):4-61. (In Russ.).
Shamalov NA, Stakhovskaya LV, Klochihina OA, Polunina OS, Polunina EA. The analysis of the dynamics of the main types of stroke and pathogenetic variants of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry/Zhurnal nevrologii i Psikhiatrii im. S.S. Korsakova. 2019;119(3 vyp 2):5-10. (In Russ.). https://doi.org//10.17116/jnevro20191190325
Skvortsova VI, Shetova IM, Kakorina EP, et al. Results of implementation of a «complex of measures to improve medical care for patients with stroke in the russian federation». Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(4):5-12. (In Russ.). https://doi.org/10.17116/jnevro2018118415-12
Tanashyan MM, Antonova KV, Lagoda OV, et al. Acute cerebral circulatory disorders and type 2 diabetes mellitus. Annals of Clinical and Experimental Neurology/Annaly Klinicheskoy i Eksperimental’noy Nevrologii. 2014;8(3):4-8. (In Russ.).
Tanashyan MM. Vascular diseases of the brain and metabolic syndrome. M.: AST 345; 2017. (In Russ.).
Shishkova VN, Adasheva TV, Remenik AYu, et al. Prognostic significance of clinical-anthropometric, biochemical, metabolic, vascular-inflammatory and molecular-genetic markers in the development of the first ischemic. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(2):4-11. (In Russ.). https://doi.org/10.17116/jnevro2018118214-11
Shishkova VN, Adasheva TV, Stakhovskaya LV. the role of diabetes mellitus and a gender factor in the development of a second noncardioembolic ischemic stroke. Vrach (The Doctor). 2020;10:50-54. (In Russ.). https://doi.org/10.29296/25877305-2020-10-09
Ostroumova OD, Surkova EV, Chikh EV. Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs. Diabetes Mellitus. 2018;21(4):307-18. (In Russ.). https://doi.org/10.14341/DM9660
Levin OS Cognitive impairment in diabetes and metabolic syndrome. Current Therapy of Mental Disorders/Sovrem. Ter. Psih. Rasstrojstv. 2015;4:18-25. (In Russ.).
Shishkova VN, Kapustina LA. Features of the development of cognitive impairment in patients with type 2 diabetes mellitus and metabolic syndrome. Vrach (The Doctor). 2018;9:3-10. (In Russ.). https://doi.org/10.29296/25877305-2018-09-01
Shishkova VN. Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention. Terapevticheskii Arkhiv. 2015;87(1):109-114. (In Russ.). https://doi.org/10.17116/terarkh2015871109-114
Parfenov VA. Dyscirculatory encephalopathy and vascular cognitive disorders. M.: IMA-PRESS; 2017. (In Russ.).
Pulina MV, Teplova MV. Rational pharmacotherapy of chronic cerebral ischemia. Clinical recommendations. M.: MEDpressinform; 2019. (In Russ.).
Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;(2):CD000269. https://doi.org/10.1002/14651858.CD000269.pub2
Singh M, Khan MI, Giri R, Kumar L. Rol of citicoline in improvement of cognition, memory and post stroke disability in stroke patients. Int J Advances Med. 2019;6(2):429. https://doi.org/10.18203/2349-3933.ijam20191154
Bogolepova AN. the role of oxidative stress in the development of vascular cognitive disorders. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(8):133-139. (In Russ.). https://doi.org/10.17116/jnevro2020120081133
Badalyan OL, Savenkov AA, Taisheva KH, et al. The possibilities of using neurox in the complex treatment of chronic brain ischemia. RMJ (Russian Medical Journal). 2010;18(8):455-459. (In Russ.).
Solovyeva EYu, Karneev AN, Chekanov AV, et al. The individual and combined antioxidant effects of citicoline and ethylmethylhydroxypyridini succinas. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2016;116(11):78-85. (In Russ.). https://doi.org/10.17116/jnevro201611611178-85
Solovyeva EYu, Karneev AN, Chekanov AV, et al. The study of membrane-protective and and antioxidant potentials of citicoline and ethylmethylhydroxypyridine with combined usage. Pacific Medical Journal. 2019;1:74-80. (In Russ.).
Solovyeva EYu, Karneev AN, Chekanov AV, et al. The study of the membrane-protective potential of the combination of 2-ethyl-6-methyl-3-hydroxypyridine-succinate and citicoline. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(1):18-22. (In Russ.). https://doi.org/10.17116/jnevro20181181118-22
Soloveva EYu, Amelina IP. cerebral small vessel disease’s impact on the development of chronic cerebral ischemia: paradigms of treatment. Medical Council/Meditsinskiy Sovet. 2020;2:16-24. (In Russ.). https://doi.org/10.21518/2079-701X-2020-2-16-24

Close metadata